journal article·2020-10

Construction of an NIR and lysosome-targeted quinoline-BODIPY photosensitizer and its application in photodynamic therapy for human gastric carcinoma cells

Jin Bai, Ying Qian

Dyes and Pigments· Volume 181
Publisher page

Abstract

Abstract In this work, a unique lysosome-targeted BODIPY photosensitizer named BOP-Lyso was designed for photodynamic therapy of cancer cells. The absorption wavelength of BOP-Lyso (10 μM) was located at 650 nm and its molar absorption coefficient was 8.2 × 104 cm−1M−1. The emission wavelength of BOP-Lyso was at 709 nm. Photosensitizer BOP-Lyso showed excellent ability to produce singlet oxygen and the singlet oxygen yield of photosensitizer BOP-Lyso was calculated to be 43.1% using methylene blue as the reference with near-infrared led light irradiation (660 nm). From MTT (a common method for determining cell survival rate, MTT: 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide) assay, BOP-Lyso had extremely low dark toxicity (cell viability > 85%) and high photo toxicity. And the IC50 value of BOP-Lyso was 0.24 μM, which was much lower than the previously reported literature. Besides that, DCFH-DA (2′,7′-Dichlorodihydrofluorescein diacetate) was employed to capture the generation of reactive oxygen species (ROS) in PDT process. Lysosomal colocalization experiments demonstrated that photosensitizer BOP-Lyso had good co-localization capability and the colocalization coefficient was calculated to be 0.92. Furthermore, photosensitizer BOP-Lyso had also been successfully applied to AO/EB cell staining experiments and exhibited excellent results. Moreover, cancer cells (SGC-7901 cells, human gastric carcinoma cells) migration status could be effectively inhibited after NIR led light irradiation with BOP-Lyso. On the whole, taking the above series of data into account, photosensitizer BOP-Lyso would play an important role in actual PDT of cancer cells.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (45)

Show source-provided references
1. Spin–orbit charge-transfer intersystem crossing (ISC) in compact electron donor–acceptor dyads: ISC mechanism and application as novel and potent photodynamic therapy reagents10.1002/chem.201904306 ↗
2. pH-triggered polypeptides nanoparticles for efficient BODIPY imaging-guided near infrared photodynamic therapy10.1021/acsami.6b01320 ↗
3. Study on liposomal encapsulation of new bodipy sensitizers for photodynamic therapy10.1021/acsmedchemlett.7b00490 ↗
4. Semiconducting polymer-based nanoparticles for photothermal therapy at the second near-infrared window10.1039/C8CC07583B ↗
5. Optimized heptamethine cyanines for photodynamic therapy10.1021/acsabm.8b00414 ↗
6. Acid-triggered nanoexpansion polymeric micelles for enhanced photodynamic therapy10.1021/acsami.9b12620 ↗
7. Engineering nanoparticles for optimized photodynamic therapy10.1021/acsbiomaterials.9b01251 ↗
8. Nanozyme decorated Metal−Organic frameworks for enhanced photodynamic therapy10.1021/acsnano.7b07746 ↗
9. A lysosome-targeted BODIPY as potential NIR photosensitizer for photodynamic therapy10.1016/j.dyepig.2017.07.048 ↗
10. Benzo[a] phenoselenazine-based NIR photosensitizer for tumor-targeting photodynamic therapy via lysosomal-disruption pathway10.1016/j.dyepig.2019.107617 ↗
11. Two-photon excited FRET dyads for lysosome-targeted imaging and photodynamic therapy10.1021/acs.inorgchem.8b01581 ↗
12. MMP2-Targeting and Redox-Responsive PEGylated Chlorin e6 Nanoparticles for Cancer Near-Infrared Imaging and Photodynamic Therapy10.1021/acsami.5b10772 ↗
13. BODIPY derivatives for photodynamic therapy: influence of configuration versus heavy atom effect10.1021/acsami.7b07569 ↗
14. Deciphering the intersystem crossing in near-infrared BODIPY photosensitizers for highly efficient photodynamic therapy10.1039/C8SC04840A ↗
15. A water soluble carbazolyl-BODIPY photosensitizer with an orthogonal D–A structure for photodynamic therapy in living cells and zebrafish10.1039/C9BM01709G ↗
16. Diplatinum (II) catecholate of photoactive boron-dipyrromethene for lysosome-targeted photodynamic therapy in red light10.1021/acs.inorgchem.9b00567 ↗
17. A near-infrared heptamethine aminocyanine dye with a long-lived excited triplet state for photodynamic therapy10.1039/C8CC04582H ↗
18. Triplet photosensitizers: from molecular design to applications10.1039/c3cs35531d ↗
19. Activatable photosensitizers: agents for selective photodynamic therapy10.1002/adfm.201604053 ↗
20. An exceptionally long-lived triplet state of red light-absorbing compact phenothiazinestyrylBodipy electron donor/acceptor dyads: a better alternative to the heavy atom-effect?10.1039/C9CC09058D ↗
21. A lysosome-localized thionaphthalimide as a potential heavy-atom-free photosensitizer for selective photodynamic therapy10.1016/j.dyepig.2020.108265 ↗
22. A ratiometric and near-infrared fluorescent probe for discrimination of Cys/Hcy/GSH in aqueous solution and its intracellular imaging in living cells10.1016/j.jlumin.2020.117055 ↗
23. Fluorescent indicators based on BODIPY10.1039/C1CS15132K ↗
24. Boron dipyrromethene (BODIPY)-based photosensitizers for photodynamic therapy10.1039/c2ra21404k ↗
25. BODIPY dyes in photodynamic therapy10.1039/C2CS35216H ↗
26. Highly photostable, lysosome-targeted BODIPYs with green to near-infrared emission for lysosome imaging in living cells10.1016/j.dyepig.2018.03.015 ↗
27. Water soluble thioglycosylated BODIPYs for mitochondria targeted cytotoxicity10.1016/j.bioorg.2019.103139 ↗
28. Synthesis, DNA/BSA binding and DNA photocleavage properties of water soluble BODIPY dyes10.1016/j.dyepig.2017.09.051 ↗
29. Synthesis, DNA interaction, in vitro/in silico topoisomerase II inhibition and photodynamic therapy activities of two cationic BODIPY derivatives10.1016/j.dyepig.2019.108072 ↗
30. Construction of a red emission BODIPY-based probe for tracing lysosomal viscosity changes in culture cells10.1016/j.snb.2019.127271 ↗
31. A novel quinoline-BODIPY fluorescent probe for fast sensing biothiols via hydrogen bonds assisted-deprotonation mechanism and its application in cells and zebrafish imaging10.1016/j.jphotochem.2018.12.013 ↗
32. Halogen-containing BODIPY derivatives for photodynamic therapy10.1016/j.dyepig.2018.08.007 ↗
33. A novel BODIPY-based photosensitizer with pH-active singlet oxygen generation for photodynamic therapy in lysosomes10.1039/C9OB01242G ↗
34. Synthesis of a triphenylamine BODIPY photosensitizer with D–A configuration and its application in intracellular simulated photodynamic therapy10.1039/C9NJ04166D ↗
35. Direct synthesis of chiral 1,2,3, 4-tetrahydropyrrolo [1,2-a] pyrazines via a catalytic asymmetric intramolecular aza-FriedelCrafts reaction10.1021/ol2018328 ↗
36. New Hg2+-selective chromo- and fluoroionophore based upon 8-hydroxyquinoline10.1021/jo034713m ↗
37. An emerging molecular design approach to heavy-atom-free photosensitizers for enhanced photodynamic therapy under hypoxia10.1021/jacs.9b09220 ↗
38. Photophysics of BODIPY-based photosensitizer for photodynamic therapy: surface hopping and classical molecular dynamics10.1021/acs.jctc.9b00533 ↗
39. Organic triplet sensitizer library derived from a single chromophore (BODIPY) with long-lived triplet excited state for triplet-triplet annihilation based upconversion10.1021/jo200990y ↗
40. Heavy atom substituted near-infrared BODIPY nanoparticles for photodynamic therapy10.1016/j.dyepig.2020.108348 ↗
41. Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapy10.1039/C9SC03355F ↗
42. High singlet oxygen yield photosensitizer based polypeptide nanoparticles for low-power near-infrared light imaging-guided photodynamic therapy10.1021/acs.bioconjchem.8b00576 ↗
43. The investigation of unique water-soluble heptamethine cyanine dye for use as NIR photosensitizer in photodynamic therapy of cancer cells10.1016/j.saa.2019.117702 ↗
44. Development of a novel anti-tumor theranostic platform: a near-infrared molecular upconversion sensitizer for deep-seated cancer photodynamic therapy10.1039/C9SC04034J ↗
45. Near-infrared quinoline-fluoroborodipyrrole dye: synthesis and lysosomal fluorescence imaging